Chemoinformaics analysis of Propyl-propanethiosulfinate
| Molecular Weight | 166.311 | nRot | 5 |
| Heavy Atom Molecular Weight | 152.199 | nRig | 0 |
| Exact Molecular Weight | 166.049 | nRing | 0 |
| Solubility: LogS | -2.216 | nHRing | 0 |
| Solubility: LogP | 2.273 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.9571 |
| nHD | 0 | BPOL | 18.6029 |
| QED | 0.461 |
| Synth | 4.893 |
| Natural Product Likeliness | -0.176 |
| NR-PPAR-gamma | 0.033 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.016 |
| Pgp-sub | 0.647 |
| HIA | 0.005 |
| CACO-2 | -4.472 |
| MDCK | 0.000038 |
| BBB | 0.884 |
| PPB | 0.819258 |
| VDSS | 1.145 |
| FU | 0.136558 |
| CYP1A2-inh | 0.092 |
| CYP1A2-sub | 0.828 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.931 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.476 |
| CYP2d6-inh | 0.034 |
| CYP2d6-sub | 0.856 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.194 |
| CL | 10.941 |
| T12 | 0.621 |
| hERG | 0.048 |
| Ames | 0.763 |
| ROA | 0.085 |
| SkinSen | 0.779 |
| Carcinogencity | 0.698 |
| EI | 0.994 |
| Respiratory | 0.841 |
| NR-Aromatase | 0.021 |
| Antiviral | No |
| Prediction | 0.972075 |